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Molecular Organization of a Zinc
Binding N-Terminal Modulatory
Domain in a NMDA Receptor Subunit
z400 amino acids (aa) of the N terminus, followed by
a domain (300 aa) related to LAOBP (lysine, arginine,
ornithine binding protein), which is split in two parts,
one preceding TM1 and the other being part of the extra-
cellular loop between TM3 and TM4 (see Figure 1A).
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Extensive characterization of the LAOBP-like domainEcole Normale Supe´rieure
of iGluRs established that this domain determines the46 Rue d’Ulm
agonist binding specificity (Stern-Bach et al., 1994; Din-75005 Paris
gledine et al., 1999), and a high-resolution crystal struc-France
ture of the LAOBP-like domain of the AMPA receptor†Syste`mes Mole´culaires et Biologie Structurale
subunit GluR2 complexed with the agonist kainate hasCNRS UMR C7590
been recently obtained (Armstrong et al., 1998). The4 Place Jussieu
overall tertiary structure of the GluR2 LAOBP-like do-75005 Paris
main is strikingly similar to that of the numerous PBPsFrance
whose structures have been solved. It consists of two
lobes that exhibit similar packing and that are connected
by two short segments defining an interlobe cleft. Kai-Summary
nate binds in the interlobe cleft and contacts multiple
residues from both lobes.Ionotropic glutamate receptors (iGluRs) bind agonists
The amino-terminal region of mGluRs displays se-in a domain that has been crystallized and shown to
quence similarity with the amino acid binding proteinshave a bilobed structure. Eukaryotic iGluRs also pos-
LIVBP and LBP (leucine binding protein; O’Hara et al.,sess a second extracellular N-terminal domain related
1993) and has been shown to play a critical role in ligandto the bacterial periplasmic binding protein LIVBP. In
recognition (Okamoto et al., 1998). Since then, a LIVBP-NMDA receptors, the high-affinity Zn inhibition is elimi-
like domain has been identified in several metabotropicnated by mutations in the LIVBP-like domain of the
receptors (family 3 of G protein–coupled receptors in-NR2A subunit. Using LIVBP structure, we have mod-
cluding the GABA-B receptor and the calcium-sensingeled this domain as two lobes connected by a hinge
receptor) in which it is proposed to form the agonistand show that six residues controlling Zn inhibition
binding site (see, for instance, Bra¨uner-Osborne et al.,form two clusters facing each other across a central
1999; Galvez et al., 1999; and see Figure 1A).cleft. Upon Zn binding the two lobes close tightly
The wealth of functional and structural informationaround the divalent cation. Thus, the extracellular re-
concerning the agonist binding domain of iGluRs andgion of NR2A consists of a tandem of Venus flytrap
mGluRs stands in deep contrast to the paucity of knowl-domains, one binding the agonist and the other a mod-
edge concerning the N-terminal LIVBP-like domain ofulatory ligand. Such a functional organization may
iGluRs. Although, recently, this latter domain has beenapply to other eukaryotic iGluRs.
shown to participate in modulation of NMDA receptor
activity (through glycine-independent desensitizationIntroduction
[Krupp et al., 1998; Villarroel et al., 1998] or proton sens-
ing [Masuko et al., 1999]) and in subtype-specific assem-L-glutamate is a major neurotransmitter in the brain of
bly of AMPA/kainate receptor subunits (Leuschner and
vertebrates and acts through either metabotropic recep-
Hoch, 1999), no detailed molecular organization of this
tors (coupled to G proteins; mGluRs) or ionotropic recep-
domain is available so far.
tors (ligand-gated ion channels; iGluRs). mGluR subunits In this study, we have used the inhibition of NMDA
possess seven putative transmembrane segments and receptors by extracellular Zn as a functional assay to
a large N-terminal extracellular domain. iGluR subunits, probe the three dimensional (3D) structure of the LIVBP-
subdivided into NMDA, AMPA, and kainate subtypes, are like domain of NR2A, a NMDA receptor subunit. Zn inhib-
thought to have a unique membrane topology with a large its NMDA receptor activity through a dual mechanism,
N-terminal extracellular region, three transmembrane a voltage-dependent channel block and a voltage-inde-
segments (TM1, TM3, and TM4), a P loop region (initially pendent reduction in probability of channel opening (see
called TM2), and a cytoplasmic C-terminal region. Dingledine et al., 1999). The voltage-independent Zn
As initially pointed out by Nakanishi et al. (1990) and inhibition (hereinafter referred to as Zn inhibition) is of
O’Hara et al. (1993), extracellular domains of both iGluRs particularly high affinity for NR2A-containing receptors
and mGluRs are distantly related to bacterial periplas- (IC50 20 nM; see Williams, 1996; Chen et al., 1997; Paoletti
mic binding proteins (PBPs). The extracellular regions et al., 1997; Traynelis et al., 1998). Recently, we found
of iGluRs are actually made of two PBP-like domains in that a region containing the LIVBP-like domain of the
tandem, a LIVBP-like domain (LIVBP for leucine, isoleu- NR2A subunit controls the high-affinity Zn inhibition of
cine, valine binding protein), which constitutes the first NMDA receptors and that four residues in this region
(H44, H128, K233, and E266) may constitute part of a
NR2A-specific Zn binding site (Fayyazuddin et al., 2000;‡ To whom correspondence should be addressed (e-mail: paoletti@
biologie.ens.fr). see also Choi and Lipton, 1999). We now combine ho-
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Figure 1. The LIVBP-Like Domain of NR2A
Controls High-Affinity Zn Inhibition of NMDA
Receptors
(A) Schematic representation of the molecu-
lar architecture of ionotropic glutamate re-
ceptors (iGluR) and of family 3 metabotropic
receptors. Both types of receptors contain an
extracellular N-terminal domain that presents
similarity with the periplasmic bacterial bind-
ing protein LIVBP. In metabotropic receptors,
this domain binds the agonist; however, in
ionotropic glutamate receptors, agonist bind-
ing occurs in another extracellular domain
showing similarity with a different periplasmic
bacterial binding protein, LAOBP. mGluR,
metabotropic glutamate receptors; CaR, cal-
cium-sensing receptors; TM, transmembrane
segment; M2, reentrant pore loop.
(B) Swapping the LIVBP-like domains be-
tween NR2A and NR2B subunits transfers the
NR2A-specific high-affinity Zn inhibition from
NR2A to NR2B. Each trace shows the inhibi-
tion of the current response to glutamate and
glycine by 50 nM Zn in oocytes expressing
NMDA receptors containing either wild-type
(wt) NR2A, wt NR2B, or chimeric NR2A/NR2B
subunits. The recordings were made at 260
mV. The bars above the current traces indi-
cate the duration of agonist and Zn applica-
tions. A schematic diagram of the NR2 con-
struct is shown on top of each trace. The
mean relative currents observed in the pres-
ence of Zn were: 0.44 6 0.01 (n 5 5) for NR2A
wt, 0.90 6 0.01 (n 5 8) for NR2B wt, 0.21 6
0.01 (n 5 7) for NR2B-(LIVBP NR2A), and
0.94 6 0.05 (n 5 4) for NR2A-(LIVBP NR2B).
mology modeling and mutagenesis to obtain a model unit with poor Zn sensitivity (IC50 1 mM) by that of NR2A
(IC50 20 nM) transfers the NR2A-specific high-affinity Znof the 3D structure of the LIVBP-like domain of the NR2A
subunit. Our data support a molecular mechanism in inhibition from NR2A to NR2B (Figure 1B). In contrast,
the converse chimera shows very little Zn sensitivity.which Zn binds in a cleft of the NR2A LIVBP-like domain
and promotes its closure. Full Zn dose response curves were constructed, and
the estimated values of IC50, maximal inhibition and Hill
coefficient were: 14 nM, 0.78 and 0.9 for NR2A wild typeResults
(wt) (n 5 2–15 for each Zn concentration tested), 760
nM, 1.0 and 0.8 for NR2B wt (n 5 2–5), 0.3 nM, 0.84 andThe LIVBP-Like Domain of NR2A Confers High
Sensitivity to Zn 0.8 (n 5 11) for NR2B-(LIVBP NR2A), and 1.5 mM, 1.0,
0.8 (n 5 3–11) for NR2A-(LIVBP NR2B). These resultsWe previously showed that a region called N1-4 made
of the first z415 residues of NR2A controls the high- demonstrate that, as already suggested by our previous
chimeras, the LIVBP-like domain of NR2A confers theaffinity Zn inhibition of NMDA receptors (Fayyazuddin
et al., 2000). As indicated by alignments between LIVBP high-affinity Zn inhibition of NMDA receptors.
and an iGluR subunit (GluR5; see O’Hara et al., 1993),
the N1-4 region extends by an z30 aa segment to the Conserved Pattern of Clusters of Hydrophobic
Amino Acids Suggests Similarity in Structuralvery N-terminal part of the agonist binding domain. In
order to specifically analyze the influence of the LIVBP- Organization between the LIVBP-Like Domains
of the NR2 Subunits and the Bacterial LIVBPlike domain on the high-affinity Zn inhibition, we con-
structed chimeric NR2 subunits in which only the first We first looked for sequences putatively related to the
LIVBP-like domain of the NR2A subunit using Psi-BLAST,z390 aa were swapped from one NR2 subunit to the
other. Replacing the LIVBP-like domain of NR2B, a sub- a program particularly well suited for uncovering weak
3D Organization of the NR2A LIVBP-Like Domain
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Figure 2. Conserved Patterns of Clusters of
Hydrophobic Amino Acids between the
LIVBP-Like Domains of the NR2 Subunits and
LIVBP
Amino acid sequence alignment of the LIVBP-
like domain of the NMDA NR2 subunits with
LIVBP from E. coli. The alignment was con-
strained by the putatively conserved second-
ary structure pattern (alternative motifs of hy-
drophobic b strands and amphipathic a
helices) detected using hydrophobic cluster
analysis (see text). The b strands (arrows), a
helices (boxes), and the linkers (L1, L2, and
L3) between the two subdomains identified
in the LIVBP crystal structure (Sack et al.,
1989a) are indicated on top of the alignment.
Gaps and insertions were admitted only in
loops connecting LIVBP secondary structure
elements. Despite the very low sequence
identities between LIVBP and any of the NR2
LIVBP-like domain (,15%), the proposed
alignment shows that most of the LIVBP
topohydrophobic residues (dark green boxes;
see Experimental Procedures for definition)
are conserved either as hydrophobic resi-
dues (dark green boxes) or T, S, or P (light
green boxes; see Experimental Procedures)
in the homologous positions of NR2 subunits
(.70% of “conserved” residues in all NR2
subunits; 85% for NR2A). Residues of LIVBP
that are strictly conserved in at least two NR2
subunits are shown in bold (41 residues out
of 344).
but biologically relevant sequence similarities (Altschul particular, no alignment of the amino-terminal domain
of any of the NR2 subunits with LIVBP or LBP has beenet al., 1997). With the first 380 residues of the rat NMDA
NR2A subunit used as the query sequence in a Psi- reported. The major difficulty in performing such align-
ments is that the percent sequence identity observedBLAST database search, a large number of sequences
with E-value better than threshold (fixed to 1023; see between LIVBP and the amino-terminal domain of NR1
or any of the NR2 subunit (10%–15%) is clearly underExperimental Procedures) appeared. They belong to the
following families: ionotropic glutamate receptors (NMDA, the limit (25%–30% sequence identity) usually consid-
ered as reliable for standard 1D sequence alignments.AMPA, and kainate receptors), orphan glutamate re-
ceptors (the d subunits), the Arabidopsis glutamate re- In order to overcome such limitations, we have used
hydrophobic cluster analysis (HCA), a sensitive two-ceptors, metabotropic glutamate receptors, atrial natri-
uretic peptide receptors, guanylate cyclase receptors, dimensional method of sequence analysis and compari-
son able to detect structural similarities between proteinGABA-B receptors, calcium-sensing receptors, phero-
mone and taste receptors, periplasmic bacterial pro- sequences sharing low levels of sequence identity (typi-
cally 15%; see Callebaut et al., 1997). This method per-teins including LIVBP and LBP, heat-stable enterotoxin
receptor, and ABC transporters. The presence of LIVBP mits one to visualize and detect secondary structure
elements containing periodically arranged hydrophobic(and LBP) in our database search indicated a putative
structural relationship between the amino-terminal re- residues. Conserved patterns of hydrophobic clusters
between distantly related sequences can then be usedgion of the NMDA NR2A subunit and LIVBP and con-
firmed the initial finding of O’Hara et al. (1993), that as “anchoring points” for constraining sequence align-
ments. Using this approach was justified by the followingionotropic glutamate receptors have an amino-terminal
region displaying sequence similarity with LIVBP. Never- observations (see Callebaut et al., 1997): (1) that the
general architecture of globular proteins (such as LIVBP)theless, after the initial observation of O’Hara et al. (1993)
and their proposed alignment of LIVBP with the amino- consists of an internal hydrophobic core surrounded by
hydrophilic residues lying on the protein surface, (2) thatterminal region of the kainate receptor subunit GluR5,
no subsequent alignment of these regions was reported the core-forming hydrophobic residues are known to be
mostly present in secondary structures (a helices anduntil the recent work of Masuko et al. (1999) on the
amino-terminal domain of the NMDA NR1 subunit. In b strands) and rarely within loops, and (3) that the most
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Figure 3. Residues of NR2A Controlling High-Affinity Zn Inhibition of NMDA Receptors All Localize in Regions Known to Participate in Ligand
Binding in Proteins Containing LIVBP-Like Domains
This multiple amino acid sequence alignment was obtained by structure superimposition for LIVBP structural neighbors (named according to
their Protein Database accession number: 2LBP for leucine binding protein, 1PEA for Pseudomonas aeruginosa amide receptor, 2DRI for
D-ribose binding protein, 5ABP for arabinose binding protein, and 1GCA for glucose/galactose binding protein). For the GABA-B receptor,
the glutamate metabotropic receptor type 1 (mGluR1) and for the calcium-sensing receptor (CaR), alignments were adapted from Galvez
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buried core-forming hydrophobic residues, which are spread throughout the sequence with best examples
being localized in b1, a2, a7, a8, b10, and b11.the main determinants of a stable fold (and therefore
called “topohydrophobic residues”; see Poupon and
Mornon, 1998), tend to be conserved as hydrophobic The Four Residues Previously Identified
as Controlling High-Affinity Zn Bindingresidues during evolution.
The sequences of LIVBP and the amino-terminal re- to NR2A Localize in Regions Known
to Participate in Ligand Binding in Proteinsgions of each of the NR2 NMDA receptor subunits were
compared pairwise using the HCA method. In every Containing LIVBP-Like Domains
In an attempt to identify residues implicated in the high-case, similar hydrophobic signatures could be detected,
the resemblance being most striking in the first z250 affinity Zn inhibition, we recently performed a point mu-
tagenesis scan through the LIVBP-like domain of theresidues (data not shown), where the pattern of alternat-
ing strongly hydrophobic b strands and amphipathic a NR2A subunit (Fayyazuddin et al., 2000). Of the 47 posi-
tions mutated, only four residues, two histidines, onehelices characteristic of LIVBP is conserved. This puta-
tively conserved secondary structure pattern was used lysine, and one glutamate (H44, H128, K233, E266), gen-
erated a “strong” phenotype when mutated individuallyto constrain the alignment of the NR2 N-terminal regions
with LIVBP (Figure 2). Despite the very low sequence (i.e., mutant NR1-NR2A receptors with greatly dimin-
ished Zn inhibition). Moreover, none of the four positionsidentities between LIVBP and any of the NR2 N-terminal
domains, the proposed alignment shows that most of affected either receptor activation by the agonists (glu-
tamate and glycine) or inhibition of the receptor activitythe topohydrophobic residues identified in LIVBP (see
Experimental Procedures for identification of topohy- by the extracellular modulators Ni21 ions or protons.
These results favored a structural model in which thedrophobic residues) are conserved as hydrophobic resi-
dues at homologous positions in the NR2 subunits (see four residues are closely associated with the Zn bind-
ing site.legend of Figure 2). Most of the conserved topohydro-
phobic residues are located at the level of LIVBP b We obtained an additional argument in favor of this
model by directly comparing the distribution of residuesstrands, as expected if the hydrophobic core of NR2
subunits is made of a central b sheet as seen in LIVBP. known or proposed to contact the ligand in different
proteins containing LIVBP-like domains with the distri-Moreover, the additional conserved topohydrophobic
residues are mostly found at the level of LIVBP a helices bution of H44, H128, K233, and E266 in the NR2A
subunit. Figure 3 shows a multisequence alignment in-and located three or four residues apart (see for instance
a2, a6, and a8). Again, this distribution is compatible cluding the alignment of Figure 2 between the NR2A
LIVBP-like domain and LIVBP. The eight additional se-with the presence in NR2 subunits of amphipathic a
helices surrounding the central hydrophobic core as quences belong to two protein families: bacterial pro-
teins on one hand (five structural neighbors of LIVBP)seen in LIVBP.
The relatively well-conserved hydrophobic patterns of and vertebrate metabotropic receptors (for GABA, gluta-
mate and calcium) on the other hand. Residues knownthe first two-thirds of the analyzed sequences produced
alignments with only a few gaps that were intentionally (from crystal structures of the different periplasmic bac-
terial proteins) or proposed (from functional studies ofintroduced in loops between secondary structure ele-
ments. The situation was much more complicated in the the different metabotropic receptors) to contact the li-
gand have been highlighted (blue boxes). This multiple-last third of the analyzed sequences. In this latter region,
many gaps had to be included in the alignments in order sequence alignment analysis reveals that the residues
directly participating in the agonist binding site are dis-to match the detected hydrophobic clusters from LIVBP
with those from the NR2 subunits. Clearly, the degree tributed in a characteristic pattern. Indeed, while they
are spread throughout the LIVBP-like domains, they allof similarity (if any) between the hydrophobic clusters in
this region is weak, rendering the positioning of putative cluster (with very few exceptions) in a few discrete loops
located between secondary structure elements. In thathomologous hydrophobic clusters rather uncertain. The
fact that the last third of LIVBP contains only small b respect, it is remarkable that, despite the wide variety
of ligands (e.g., amino acids, monosaccharides, ions,strands located at the periphery of the core of the central
b sheet suggests that this region is less important as etc.) recognized by these protein families, the different
LIVBP-like domains share common regions participatingcontrolling the fold than the rest of the protein and there-
fore could be subjected to a higher structural divergence in ligand binding. Strikingly, the four residues that we
previously identified as controlling Zn binding in NR2A allduring evolution.
The proposed sequence alignment also shows iden- localize to such regions (loop b1/a1 for H44, loop b4/a4
for H128, loop b8/a8 for K233, and loop b9/a9 for E266;tity clusters between the NR2 N-terminal regions and
LIVBP (see bold letters in Figure 2). Such clusters are green boxes).
et al. (1999, 2000), Hampson et al. (1999), and Bra¨uner-Osborne et al. (1999), respectively. For the NR2A subunit, we used the alignment
between LIVBP and NR2A proposed in Figure 2. The b strands (arrows) and a helices (boxes) identified in the LIVBP crystal structure (Sack
et al., 1989a) are indicated on top of the alignment. The large insertions found in the GABA-B receptor, in mGluR1, and in CaR have been
removed and are indicated by I1 to I4. Blue boxes indicate residues known (for 2LIV, 1PEA, 2DRI, 5ABP, and 1GCA) or proposed (for 2LBP,
GABA-B, mGluR1, and CaR) to contact the ligand molecules (see Experimental Procedures for references). They all cluster in discrete regions
spread throughout the domain. Residues of NR2A-controlling Zn inhibition of NMDA receptors (H44, H128, K233, and E266 [green boxes]
previously identified by Fayyazudin et al. [2000] and D102, D105 [red boxes] identified in the present work) all localize to such regions.
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Figure 4. NR2A D102, an Additional Residue
Controlling High-Affinity Zn Inhibition, Identi-
fied on the Basis of the Proposed Sequence
Alignment
(A) Comparison of the current traces obtained
from two oocytes expressing either wt NR1/
NR2A receptors or mutated NR1/NR2A-D102A
receptors. Zn was applied at increasing con-
centrations (5, 50, and 500 nM) during an ap-
plication of glutamate and glycine. The re-
cordings were made at 260 mV. The bars
above the current traces indicate the duration
of agonist and Zn applications.
(B) Zn dose-response curves of wt NR1/NR2A
and NR1/NR2A-D102A receptors. For Zn
concentrations ,1 mM, tricine (10 mM) was
used to buffer Zn. Currents were measured
at voltages at which voltage-dependent Zn
block is virtually absent (see Experimental
Procedures). The curves represent least-
square fits to the data points with the Hill
equation. The estimated values of IC50, maxi-
mal inhibition, and Hill coefficient are: 14 nM,
0.78 and 0.9 for wt NR1/NR2A receptors and
6.5 mM, 0.87 and 1.2 for NR1/NR2A-D102A
receptors, respectively. Each point is the
mean value of 2–15 cells for NR1/NR2A re-
ceptors and 2–5 cells for NR1/NR2A-D102A
receptors.
Identification of Two Additional Residues is as marked as those observed with each of the four
“strong” mutants previously identified. The residual ZnControlling Zn Binding to NR2A Based
on the Proposed Sequence Alignment sensitivity retained by the mutated receptors (see, for
instance, the inhibition of the current produced by 500In our previous study (Fayyazuddin et al., 2000), no resi-
due critical for Zn binding had been identified in three nM Zn [Figure 4A]) is consistent with the proposal that
all NMDA receptor types possess a low-affinity Zn bind-of the ligand-contacting “hot spots” identified in Figure
3, i.e., loop b3/a3, regions b6/a6, and a11. In NR2A, the ing site that, in the case of NR2A-containing receptors,
is located outside the LIVBP-like domain (see Fayyazud-residues lining both the b6/a6 and a11 regions are poor
candidates for Zn coordination except for D182 (region din et al., 2000). In contrast to the NR2A-D102A and
NR2A-D105A mutations, the NR2A-D103A mutation onlyb6/a6) and E308 (region a11). However, we previously
showed that neither mutation D182S nor E308Q signifi- moderately decreased Zn sensitivity (see Table 1),
whereas Zn sensitivity of NR2A-E107A mutant receptorscantly altered high-affinity Zn inhibition (Fayyazuddin et
al., 2000). In contrast, the b3/a3 region of NR2A contains was slightly increased (the ratios IZn/I0Zn for 5, 50, and
500 nM Zn were, respectively [n 5 5]: 0.49 6 0.04, 0.27 6a cluster of good candidates for Zn coordination (D102,
D103, D105, and E107; see Figure 3). We mutated each 0.03, and 0.21 6 0.03). These results indicate that D103
and E107 are not likely to participate in the direct coordi-of these residues individually in order to test their influ-
ence on Zn sensitivity. Mutants were screened by mea- nation of Zn.
H44, D102, D105, H128, K233, and E266 are the onlysuring the level of inhibition at three concentrations of
Zn: 5 nM, a concentration below the IC50 of NR2Awt- positions in NR2A so far identified where a substitution
by either A or S strongly reduces the Zn affinity. In suchcontaining receptors, 50 nM, a concentration 3-fold
higher than the control IC50, and 500 nM, a saturating mutants, the observed Zn IC50 is in the low micromolar
range, i.e., similar to that of non-NR2A-containing recep-concentration for these receptors. Mutation of two resi-
dues (D102 and D105) out of the four residues tested in tors. In fact, mutating one of those six positions is as
effective in shifting the apparent Zn affinity as deletingthe b3/a3 region strongly reduced apparent Zn affinity.
The results obtained with the NR2A-D102A mutation the entire NR2A LIVBP-like domain (see Fayyazuddin et
al., 2000). The central role played by these residues inshow that the mutated receptors display very little sensi-
tivity to Zn compared to wild-type receptors (Figure 4A). controlling Zn inhibition was confirmed by carrying out
a series of mutations in which the critical residues wereSimilar results were obtained with the NR2A-D105A mu-
tation (see Table 1). Full Zn dose inhibition curves were individually replaced by residues usually found in Zn
binding sites (C, H, E, and D; see Glusker, 1991). Asobtained for the NR2A-D102A mutation (Figure 4B),
showing a 500-fold increase of IC50 compared to the shown in Table 1, most of the substitutions tested (with
the noticeable exception of the E266 position) displayedwild-type receptors. The observed shift in Zn sensitivity
3D Organization of the NR2A LIVBP-Like Domain
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sion), the scores obtained were in the range of scoresTable 1. Effects on Zn sensitivity of Various NR2A Mutations
at the Six Critical Positions Identified as Controlling obtained for highly refined X-ray structures.
High-Affinity Zn inhibition The overall secondary and tertiary structure organiza-
tions are illustrated in Figure 5A and, as expected fromNR2A Mean Relative Current (IZn/I0Zn)
homology modeling, the modeled NR2A LIVBP-like do-
n
Mutant 5 nM Zn 50 nM Zna 500 nM Zn
main share major common structural features with the
wt 0.77 6 0.06 0.41 6 0.06 0.28 6 0.05 35 unliganded form of LIVBP: (1) it consists of two distinct
globular subdomains (or lobes) separated by a deepH44A ND 0.99 6 0.01 0.78 6 0.03 3
H44C ND 0.97 6 0.01 0.87 6 0.03 3 groove or cleft; (2) each lobe shows alternation of b
H44E ND 0.95 6 0.01 0.84 6 0.02 4 strands and a helices arranged as a buried central b
H44K ND 0.93 6 0.01 0.82 6 0.01 3 sheet flanked on both sides of the plane of the sheet
D102A 1.0 6 0.01 0.99 6 0.01 0.92 6 0.01 13 by a helices; (3) the two lobes are interconnected by a
D102C 1.0 6 0.0 0.99 6 0.0 0.92 6 0.01 4 hinge made of three short linkers. The lobe containing
D102H 1.0 6 0.0 1.0 6 0.0 0.95 6 0.01 3
the most N-terminal amino acid will be referred to asD102E 1.0 6 0.0 1.0 6 0.0 0.94 6 0.01 3
lobe I (top lobe in Figure 5A) and the other as lobe II.D102K 1.0 6 0.0 1.0 6 0.0 0.93 6 0.01 5
The modeled structure is z80 A˚ in length and has aD105A 0.97 6 0.03 0.92 6 0.05 0.78 6 0.06 5
maximal cross-sectional dimension of z45 A˚.D105C 1.0 6 0.0 0.98 6 0.01 0.84 6 0.02 4
Figure 5B displays the six residues identified as con-D105E 0.65 6 0.03 0.37 6 0.03 0.31 6 0.02 10
trolling high-affinity Zn binding to NR2A (see Figures 3H128S 1.0 6 0.0 0.99 6 0.01 0.93 6 0.01 7
and 4, and Table 1). The six residues all belong to regionsH128C ND 0.94 6 0.01 0.89 6 0.01 3
H128E 0.94 6 0.01 0.91 6 0.01 0.85 6 0.01 3 lining the cleft and project from both lobes into the cleft
(lobe I for H44, D102, D105, and H128; lobe II for K233K233S ND 0.93 6 0.03 0.81 6 0.03 3
K233C 0.93 6 0.01 0.90 6 0.01 0.80 6 0.01 3 and E266). In each lobe, the a carbons of the critical
K233H 0.95 6 0.02 0.91 6 0.02 0.84 6 0.01 3 residues are close (separated by less than 10 A˚) with
K233R ND 1.0 6 0.01 0.90 6 0.05 3 respect to each other, i.e., in positions compatible with
K233E 0.97 6 0.01 0.95 6 0.01 0.86 6 0.01 3
direct Zn coordination (see Krovetz et al., 1997). The
E266A ND 0.98 6 0.02 0.90 6 0.04 3 residues from lobe I and lobe II face each other, but
E266S ND 0.98 6 0.02 0.85 6 0.04 3
in this conformation (similar to the unliganded form ofE266C 0.84 6 0.02 0.73 6 0.01 0.56 6 0.01 3
LIVBP), they are separated by z14 A˚ across the cleft.E266H 0.84 6 0.04 0.67 6 0.04 0.51 6 0.03 8
This is too large a distance for coordinating a single ZnE266D 0.96 6 0.01 0.82 6 0.03 0.59 6 0.03 5
E266K 1.0 6 0.0 0.95 6 0.02 0.86 6 0.02 6 ion. This suggests that the closure of the cleft promoted
E266R 0.97 6 0.01 0.95 6 0.02 0.87 6 0.01 4 by ligand binding, which has been observed in all PBP
proteins (Quiocho and Ledvina, 1996), may also occura For each mutant except D105E, the mean relative current mea-
sured at 50 nM Zn is significantly different from the wild-type value upon Zn binding in NR2A (see the end of the Results
(P , 0.001, F test). section) so that the critical residues from lobe I and lobe
II participate together to coordinate Zn.
Experimental Validation of the 3D Model
similar phenotypes as the A or S substitutions with
As a first step, we reexamined in our model each of the
strongly reduced Zn affinity. We also tried to reconstitute
mutations (other than the “strong” mutations) that we
an artificial but functional high-affinity Zn binding site
had previously tested for Zn sensitivity (most of them
by simultaneously replacing multiple critical residues or
being charged polar residues, histidines, or cysteines;
by swapping pairwise critical residues. Once again, each
see Table 1 of Fayyazuddin et al., 2000) and tried to
one of the mutant receptor tested (containing either
correlate their phenotypes and their location in the
NR2A-H44C-H128C, NR2A-H44K-H128E, NR2A-K233C-
model. The vast majority (32 residues out of 35) of the
E266C, NR2A-K233H-E266H, or NR2A-K233E-E266K)
mutations that produce little or no effect on Zn sensitivity
showed a strong reduction in Zn affinity (data not shown).
either belong to regions localized far from the residues
participating in Zn binding and/or have their side chain
that does not point toward the cleft (this is the case ofModel of the 3D Structure of the NR2A
LIVBP-Like Domain mutations at positions E19, D45, R49, H85, C87, D88,
H96, Q132, D133, H168, D192, D212, K214, H223, C231,We modeled the 3D structure of the NR2A LIVBP-like
domain by homology to the known structure of the unli- E235, E242, D252, K270, E271, D285, E289, E308, C320,
E328, H332, H335, E352, E353, H358, E371, and E373).ganded form of LIVBP (PDB coordinates 2LIV; Sack et
al., 1989a) on the basis of the sequence alignment Two positions, D78 and D207, which display intermedi-
ate Zn sensitivity when mutated to an alanine, are spa-shown in Figure 2. The model was produced by Modeller
4 (Sali and Blundell, 1993) and is presented in Figure 5. tially well separated (D78 on lobe I and D207 on lobe
II), yet both map at the mouth of the cleft. Given theWe first assessed the model using the Verify 3D algo-
rithm (Luthy et al., 1992). The calculated three/one-dimen- localization of these acidic residues at the “entrance”
of the cleft, it is tempting to speculate that they createsional scores were mostly positive and did not differ by
a large amount from those obtained with the template an electrostatic environment favoring the entry of Zn21
ions in the cleft (see below for additional support of thisstructure LIVBP (data not shown). Except at two loca-
tions (residues 60–80 and 190–220, some of which could hypothesis). The marked increase in Zn affinity observed
with the R244G mutation is difficult to explain by a simpletake part in protein–protein interactions; see Discus-
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Figure 5. Three-Dimensional Model of the LIVBP-Like Domain of the NR2A Subunit
This model was produced by homology modeling using the sequence alignment shown in Figure 2 and the Protein Data Bank coordinates
of LIVBP (2LIV), the unliganded form of LIVBP.
(A) Ribbon representation of the secondary and tertiary structure organization. As expected from the structure of LIVBP, the domain is made
of two lobes connected by a three-segment hinge defining a interlobe cleft. Each lobe is made of a central b sheet (b strands are highlighted
in green) surrounded by a helices (red).
(B) The putative Zn binding site. The six residues identified as controlling high-affinity Zn inhibition are displayed in spacefill and Corey-
Pauling-Koltun representation. These residues belong to regions lining the cleft and project their side chains from both lobes into the cleft
(lobe I for H44, D102, D105, and H128; lobe II for K233 and E266) facing each other. Also shown are five positions that were specifically
mutated to probe the validity of the model and/or putative conformational changes associated with Zn binding: D78 (lobe I) and D207 (lobe
II) at the entrance of the cleft, S259 and S262 close to the putative Zn binding site, and Y281 in the back of the cleft with its side chain pointing
toward the center of the cleft.
electrostatic mechanism since, in our model, this resi- localized at the “entrance” of the cleft, and (3) residues
with an a carbons or side chain close to the a carbondue is localized in a8 at a distance of more than 20 A˚
from the cleft. However, as we showed previously (see or side chain of one (or more) of the critical residues.
Group (1) mutations aimed at testing the idea thatFayyazuddin et al., 2000), this mutation is not specific
for the Zn modulation and could affect gating at a point buried hydrophobic residues participating in multiple
hydrophobic contacts are essential for the proper fold-distant from the Zn binding step itself. Finally, only very
few positions show functional phenotypes difficult to ing of the domain. Among the residues located in b
strands in the hydrophobic nucleus at positions homolo-reconcile with their position in the model. This is particu-
larly the case for the D234 position, which shows unal- gous or close to the topohydrophobic residues found
in LIVBP (see Figure 2), we chose L98, V173, and W255tered Zn sensitivity (when mutated to an alanine),
whereas its location (with its side chain close to K233 (in b3, lobe I and b6 and b9, lobe II, respectively). We
replaced them individually by an aspartate, a residueand E266) suggests that it could aid in the correct posi-
tioning of these two critical residues. that is rarely found in regular secondary structures but
has a strong propensity to participate in the formationIn a second step of the validation of the model, we
generated a series of point mutations targeted to resi- of loops (see Callebaut et al., 1997). In agreement with
their proposed role in the correct folding of the domain,dues chosen for their specific locations in the model
hoping to produce altered phenotypes in a predictable all three mutations (L98D, V173D, and W255D) yielded
nonfunctional receptors. The lack of functional expressionway. To maximize the contribution of such an approach,
we selected nine residues that were scattered at differ- was not studied further but could result from improper
subunit assembly or perturbed cellular trafficking.ent locations in the structure (lobe I, lobe II, hinge). These
residues were classified in three groups, according to Group (2) mutations aimed at testing the idea that
charged residues localized at the “entrance” of the clefttheir location in the model: (1) buried residues of the
hydrophobic central core, (2) exposed charged residues provide an electrostatic environment that may influence
3D Organization of the NR2A LIVBP-Like Domain
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Figure 6. Experimental Validation of the 3D
Model of the NR2A LIVBP-Like Domain
Zn sensitivity of wild-type and mutated
NMDA receptors was assessed by applying
increasing Zn concentrations (5, 50, and 500
nM) during an application of glutamate and
glycine. The bars above the current traces
indicate the duration of agonist and Zn appli-
cations. Responses were recorded at 260 mV
and normalized to the initial peak current in
the absence of Zn for superimposition.
(A) The effects of charge-altering mutations
at the NR2A D207 position on Zn sensitivity.
Progressive decrease in Zn sensitivity going
from charge conservation (D to E mutation)
to charge neutralization (D to A mutation) and
to charge inversion (D to K mutation). In the
proposed model, D207 localizes to lobe II at
the entrance of the cleft (see Figure 5). For
clarity, mutant traces were slightly shifted in
time. Inset: mean relative current measured
at 50 nM Zn for the different mutations at
position 2AD207 (see Table 2 for values).
(B) The NR2A S259 position. As expected
from its localization in the proposed 3D model
(in close proximity of the putative Zn binding
site; see Figure 5) mutating this position to
an alanine (A) barely affects Zn sensitivity
while the arginine (R) mutation strongly re-
duces Zn sensitivity.
the efficiency with which Zn binds to its site. The two each selected residue to an alanine in order to verify
that such mutants differed from “strong” mutants. Thispositions D78 (in lobe I) and D207 (in lobe II) were good
candidates to play such a role (see above). We mutated was indeed observed (see Figure 6B and Table 2). We
then mutated each residue to an arginine (except forthese two residues with either charge conservation (sub-
stitution by an E) or charge inversion (substitution by a D103 which was mutated to K). As shown in Figure 6B
and Table 2, such mutations produced receptors withK). As shown in Figure 6A and Table 2, as the charge
at 78 or 207 becomes more positive (D ! A ! K), the drastically reduced Zn inhibition. In fact, the magnitude
of the effects were comparable to those observed withmutant receptors become progressively less sensitive
to Zn inhibition. As expected for an electrostatic mecha- A or S mutations at the critical residues (“strong” muta-
tions; see Table 1).nism, the D ! E substitution at position 207 resulted in
a phenotype close to wild type. However, this was not
the case at the 78 position, indicating clearly that effects Zn Binding Prevents MTSET Accessibility
to Cysteines Engineered in the Backother than simple electrostatics are involved.
Group (3) mutants aimed at testing the idea that resi- of the Cleft
Crystallographic studies of a number of periplasmicdues located in close proximity of the critical residues
should have a profound effect on Zn inhibition when binding proteins have revealed that these proteins can
adopt either an “open” or a “closed” conformation de-mutated to a positively charged residue. Residues D103,
S259, S262, and Y281 were chosen for that purpose. pending on the absence or presence of the ligand. In
the “closed” conformation, the ligand is nestled in theD103 (in lobe I) is adjacent to the “strong” positions
D102 and D105 (see Figure 3), S259 and S262 (in lobe interlobe cleft and contacts residues from both lobes.
In the “open” ligand-free conformation, the two lobes areII) both localize in the b9/a9 loop known to be implicated
in ligand recognition in a number of LIVBP-like domains further apart, rendering the cleft between the lobes more
open and solvent accessible. The ligand appears there-(see Figure 3), and Y281 (in the hinge) projects its side
chain toward the cleft close to H44. We first mutated fore to induce a hinge-bending motion (also called the
Neuron
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Table 2. Effects on Zn Sensitivity of Various NR2A Mutations at Positions Selected for Experimental Validation of the Proposed 3D
Model of the NR2A LIVBP-Like Domain
NR2A Mean Relative Current (IZn/I0Zn) n
Mutant 5 nM Zn 50 nM Zn 500 nM Zn
L98D no functional expression .20
V173D no functional expression .20
W255D no functional expression .20
D78E 0.94 6 0.03 0.75 6 0.01 0.41 6 0.02 5
D78C 0.92 6 0.01 0.62 6 0.03 0.31 6 0.03 6
D78A 0.93 6 0.03 0.74 6 0.02 0.41 6 0.02 6
D78K 0.93 6 0.02 0.84 6 0.03 0.63 6 0.06 15
D207E 0.82 6 0.03 0.44 6 0.05 0.27 6 0.04 9
D207A 0.93 6 0.01 0.67 6 0.01 0.40 6 0.01 6
D207K 0.96 6 0.01 0.80 6 0.02 0.55 6 0.03 10
D103A 0.94 6 0.02 0.71 6 0.04 0.42 6 0.04 10
D103K 1.0 6 0.0 1.0 6 0.0 0.87 6 0.02 6
S259A 0.72 6 0.02 0.34 6 0.02 0.23 6 0.01 10
S259R 0.98 6 0.01 0.97 6 0.01 0.88 6 0.02 10
S262A 0.97 6 0.01 0.83 6 0.01 0.58 6 0.01 7
S262R 1.0 6 0.01 0.97 6 0.01 0.88 6 0.01 3
Y281A 0.40 6 0.01 0.28 6 0.01 0.24 6 0.01 8
Y281R 1.0 6 0.0 1.0 6 0.0 0.85 6 0.03 3
C399A-S259C 0.73 6 0.02 0.33 6 0.04 0.23 6 0.03 10
C399A-S262C 0.89 6 0.03 0.68 6 0.03 0.43 6 0.02 4
C399A-Y281C 0.37 6 0.04 0.35 6 0.04 0.32 6 0.03 10
Pairwise significance of the differences in the mean relative currents were calculated at 50 nM Zn using an F test. For the D78 position:
significant differences (P , 0.001) were obtained for the pairs E/wt, C/E, A/C/ K/A, and K/wt; the value obtained with the A mutant is not
significantly different from that obtained with the E mutant. For the D207 position: significant differences (P , 0.001) were obtained for the
pairs A/E, K/A, and K/wt; the value obtained with the E mutant is not significantly different from that obtained with the wt. For the D103
position, significant differences (P , 0.001) were obtained for the pairs A/wt, K/A, and K/wt. For the S259, S262, and Y281 positions, significant
differences (P , 0.001) were obtained for the pairs A/wt, R/A, and R/wt.
“Venus flytrap” model) through the stabilization of the 7C. Marked reduction of Zn inhibition after MTSET treat-
ment in Zn-free solutions was expected from the“closed” structure (see Quiocho and Ledvina, 1996).
To probe for a similar conformational change oc- “strong” phenotypes previously observed with the R
substitution at the corresponding positions (see Figurecurring in the LIVBP-like domain upon Zn binding, we
used the substituted cysteine accessibility method 6B and Table 2).
These results are fully consistent with the idea that(SCAM; Akabas et al., 1992) and reasoned that Zn bind-
ing to the NR2A LIVBP-like domain should protect Zn, as the ligand in periplasmic bacterial proteins, binds
in the cleft and promotes its closure by a hinge mecha-against chemical modification of cysteines introduced
within the cleft. Our choice of the positions where cyste- nism. This mechanistic interpretation is cartooned in
Figure 8 based on the Y281C protection experiment. Weines were introduced was dictated by the following re-
quirements: (1) the residue should have its side chain propose that the NR2A LIVBP-like domain can adopt
two conformational states: an “open” conformation withaccessible to water in the “open” configuration, (2) the
residue should be deep enough in the cleft to have a much of the cleft exposed to solvent and a “closed”
conformation with the two lobes in closer proximity. Wegood chance to be buried in the “closed” configuration,
and (3) the cysteine substitution (not modified by also propose that the high-affinity binding of Zn, by
requiring determinants located on both faces of the cleft,MTSET) should maintain a potent Zn inhibition since we
used Zn sensitivity as our functional assay. S259, S262, strongly stabilizes the “closed” conformation. Thus, in
Zn-free conditions, MTSET can attack and covalentlyand Y281 met these criteria (see Figure 5 and Table 2).
We used the positively charged reagent MTSET link to cysteines introduced deep in the cleft. This results
in impaired Zn binding because of steric hindrance and/(methane-thio-sulfonate-ethyltrimethylammonium) to re-
act with the substituted cysteines. Figure 7 shows the or electrostatic repulsion (Figure 8B, top panels). Con-
versely, prior closure of the cleft induced by Zn pre-results of a typical SCAM experiment for the Y281C
mutation. A 2 min treatment by 100 mM MTSET (in Zn- cludes MTSET from reaching its target because of poor
accessibility and/or electrostatic repulsion exerted byfree conditions; see Experimental Procedures) induced
a strong reduction in the amount of Zn inhibition (Figure Zn21 ions. Consequently, the Zn sensitivity remains unal-
tered (Figure 8B, lower panels).7A). This effect was virtually abolished if MTSET was
applied in the presence of a saturating concentration of
Zn (10 mM Zn applied before and during MTSET treat- Discussion
ment and MTSET wash; see Figures 7B and 7C). Similar
results (however with partial protection) were observed Previous studies have shown that the N-terminal region
of the NR2A subunit, the LIVBP-like domain, containswith the S259C and S262C mutations as shown in Figure
3D Organization of the NR2A LIVBP-Like Domain
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Figure 7. Zn Binding Protects Cysteines In-
troduced in the Back of the Cleft from Reac-
tion with MTSET
The three positions, S259, S262, and Y281,
chosen for their location deep in the cleft (see
Figure 5) were individually substituted by a
cysteine. The positively charged reagent
MTSET (methane-thio-sulfonate-ethyltrimethyl-
ammonium) was used to chemically modify
the introduced cysteines. MTSET was ap-
plied in the presence or absence of a saturat-
ing concentration of Zn. In each experiment,
Zn sensitivity was assessed in the absence
of MTSET before and after treatment by the
MTS reagent with three different Zn concen-
trations (500, 50, and 5 nM) applied during
an application of glutamate and glycine. To
separate the effects of MTSET on constitutive
cysteines from those on introduced cyste-
ines, these experiments were made in a back-
ground of the mutated NR2A-C399A subunit
(see Experimental Procedures).
(A) Under Zn-free conditions, the cysteine en-
gineered at position NR2A Y281 appears to
be solvent accessible as indicated by the
strong reduction in Zn apparent affinity ob-
served after a 2 min treatment by 100 mM
MTSET.
(B) These effects are fully abolished if MTSET
is applied in the presence of a saturating in-
hibitory Zn concentration (10 mM Zn applied
before, during MTSET treatment and during
MTSET wash). The bars above the current
traces indicate the duration of agonist and
Zn applications. Responses were recorded at
260 mV. Current traces in (A) and (B) are from
two different cells.
(C) Pooled data of the protection experiments
at position S259, S262, and Y281. In each
experiment, the ratio of the current measured
in the presence of Zn (500 nM for S259C and
S262C and 5 nM for Y281C) over the current
measured in the absence of Zn was calcu-
lated before and after treatment by MTSET
alone or MTSET plus Zn. MTSET applied at
100 mM or 1 mM for 2 min; Zn applied at 10
mM for the Y281 position and 100 mM or 1 mM
for the S259 and S262 positions). The mean
ratios (control, post MTSET, and post Zn/MTSET, respectively) are: 0.23 6 0.03 (n 5 10), 0.64 6 0.11 (n 5 5), and 0.44 6 0.10 (n 5 5) for
S259C; 0.43 6 0.02 (n 5 4), 0.65 6 0.07 (n 5 4), and 0.48 6 0.005 (n 5 2) for S262C; and 0.37 6 0.04 (n 5 14), 0.85 6 0.04 (n 5 13), and
0.38 6 0.01 (n 5 6) for Y281C.
determinants of the high-affinity Zn inhibition of NMDA plasmic bacterial proteins) map to homologous regions;
(3) the “closure” mechanism shown to be induced byreceptors (Choi and Lipton, 1999; Fayyazuddin et al.,
2000). In the present work, we have characterized the ligand binding in periplasmic bacterial proteins is con-
sistent with our experiments using MTSET.molecular mechanism of the initial step of this inhibition.
Validity of the 3D Model of the NR2A The High-Affinity Zn Binding Site and Conformational
Changes of the NR2A LIVBP-Like DomainLIVBP-Like Domain
Our structure/function analysis of the high-affinity Zn Induced by Zn Binding
The present study combined with our previous workinhibition of NR2A-containing NMDA receptors fully con-
firms the initial proposal of O’Hara et al. (1993) that (Fayyazuddin et al., 2000) shows that six NR2A residues,
H44, D102, D105, H128, K233, and E266, play a criticaliGluR subunits contain an N-terminal LIVBP-like domain.
Three different lines of evidence support this conclusion: role in controlling high-affinity Zn binding to the LIVBP-
like domain. Although we do not have direct proof that(1) the secondary structure pattern (and thus the protein
fold) is conserved between the bacterial LIVBP and the these residues actually coordinate Zn, several argu-
ments support the hypothesis that these residues areNR2 N-terminal domains; (2) the residues involved in
ligand binding (Zn in the case of NR2A; several different closely associated with the Zn binding site. First, these
positions are the only ones in the NR2A LIVBP-like do-ligands in family 3 metabotropic receptors and in peri-
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Figure 8. The Extracellular Region of the
NR2A Subunit Consists of Two Venus Flytrap
Domains in Tandem
(A) The NR2A subunit is a modular protein
made of (at least) four functional domains:
a modulatory N-terminal LIVBP-like domain
specialized in Zn sensing, a LAOBP-like do-
main which binds the agonist L-glutamate, a
transmembrane domain that forms the pore,
and a cytoplasmic C-terminal domain that in-
teracts with intracellular components.
(B) Functioning of the NR2A LIVBP-like
domain: a mechanistic interpretation of the
experiments using MTSET on NR2A-Y281C
receptors (see Figure 7). See text for explana-
tions.
main that produce large shifts in Zn sensitivity when tering the ligand (see Quiocho and Ledvina, 1996). Thus,
overall, our data strongly support the hypothesis thatmutated to an A or an S but also to most other substitu-
tions tested (see Table 1). Second, the large effects H44, D102, D105, H128, K233, and E266 directly contrib-
ute to the formation of the high-affinity Zn binding siteinduced by these mutations are specific for the high-
affinity Zn inhibition (see Fayyazuddin et al. [2000] and either by intimately participating in Zn recognition or by
directly coordinating it.unpublished data for D102). Third, the nature of the
side chain (carboxyl groups of D102, D105, and E266; The location of the putative Zn binding residues in the
modeled structure, two groups of residues facing eachimidazole groups of H44 and H128) is compatible with
direct Zn coordination (for the amino group of K233 other across the cleft and separated by z14 A˚ (see
Figure 5), suggests that the conformational change ob-see Discussion in Fayyazuddin et al., [2000]), and Zn
coordination can accommodate an octahedral geometry served upon ligand binding in PBPs, i.e., cleft closure,
is present in the NR2A LIVBP-like domain. Indeed, 14 A˚(with a coordination number of six; see Glusker [1991]).
Fourth, all six residues map to regions known to partici- is clearly too large a distance for critical residues from
both lobes to span in order to form a high-affinity Znpate in ligand recognition in proteins containing LIVBP-
like domains (see Figure 3) and thus are well positioned binding site, but cleft closure could allow the formation
of such a site. By using the SCAM method, we havefor lining the wall of the cleft. Finally, the location of the
residues in the model (two groups of residues, one in obtained experimental evidence supporting this hypoth-
esis (see Figures 7 and 8). Although we cannot rule outeach lobe facing each other across the cleft) is reminis-
cent of what has been observed with the PBPs. Indeed, the possibility that Zn prevents access of MTSET to the
substituted cysteines through an electrostatic mecha-in all the structures of the closed cleft liganded form of
PBPs, both lobes participate in interacting and seques- nism independent of cleft closure, the effects are more
3D Organization of the NR2A LIVBP-Like Domain
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simply explained by a model involving a hinge-twist mo- intersubunit contacts is also supported by work on
AMPA receptors showing that the N-terminal region oftion between the two lobes (see Figure 8). Accordingly,
the enhanced Zn sensitivity observed with the Y281A these receptors mediate subtype-specific subunit as-
sembly (Leuschner and Hoch, 1999) and that isolatedor Y281C mutations (see Table 2) may derive from the
fact that the wild-type tyrosine could disfavor cleft clo- fragments containing the LIVBP-like domain in tandem
with the LAOBP-like domain spontaneously dimerize,sure due to steric hindrance (Y281, located in the hinge,
has its bulky side chain pointing toward the cleft; see whereas fragments made of the LAOBP-like domain
alone are monomeric (Kuusinen et al., 1999). Thus,Figure 5) in contrast to the small side chain group of an
alanine or a cysteine. change in the strength of intersubunit bonds may also
participate to the transfer of the Zn-induced conforma-
tional change in the LIVBP-like domain to the gatingTransferring the Zn-Induced Conformational
machinery.Change in the LIVBP-Like Domain
to the Gating Machinery
How does the Zn-bound LIVBP-like domain interact with Modular Architecture of iGluRs and the Role(s)
of the LIVBP-Like Domainsthe rest of the protein to inhibit channel activity? This
problem remains largely unsolved, in particular for iGluRs From a large number of studies (see Dingledine et al.,
1999), it now appears clear that eukaryotic iGluRs arein which the location of the gate is still unknown. How-
ever, the following two pieces of information could give built as modular proteins made of (at least) four distinct
functional domains (see Figure 8): (1) an N-terminala hint of how the LIVBP-like domain interacts with the
rest of the protein: first, we observed that the identity LIVBP-like domain that modulates receptor activity by
binding Zn in the case of the NR2A subunit, (2) an agonistof the segment connecting the LIVBP-like domain to the
LAOBP-like domain in the NR2 subunit influences Zn binding LAOBP-like domain that binds glycine in the
NR1 subunit and L-glutamate in all other subunits, (3) ainhibition, and second, it has been shown that the
LIVBP-like domain of family 3 metabotropic receptors transmembrane domain that contains a reentrant loop
forming the pore, and (4) a cytoplasmic C-terminal do-dimerizes.
The z20 aa segment (N-linker) linking the LIVBP-like main that interacts with a large number of intracellular
components including cytoskeletal and signal transduc-domain to the LAOBP-like domain is obviously a good
candidate to transduce conformational changes of the tion molecules. The recent discovery of a prokaryote
iGluR, the GluR0 subunit (Chen et al. 1999), related inLIVBP-like domain to other parts of the protein. An initial
clue in this direction comes from our previous work amino acid sequence and function to both eukaryotic
iGluRs (in the agonist binding domain) and potassiumshowing that a region including the N-linker (the so-
called N4 region in Fayyazuddin et al., 2000) influences channels (in the pore and selectivity filter), strongly sup-
ports the view that iGluRs have been constructedZn sensitivity. This indication is strengthened by our
present results obtained with the NR2A/NR2B LIVBP- through assembly of preexisting modules or domains.
Each domain fulfills a precise function. In that respect,like domain chimeras (see Figure 1). Hence, a possible
cascade of consecutive conformational changes in- the fact that GluR0 lacks an N-terminal LIVBP-like do-
main indicates that this domain is not essential for gatingduced upon Zn binding could be the following: closure
of the cleft of the LIVBP-like domain, tranduction by the but rather has a modulatory role (see Chen et al., 1999).
This observation agrees with our previous observationN-linker, change of the strength of the tension exerted
by the LAOBP-like domain on the membrane domain that truncated NR2A subunits lacking the entire LIVBP-
like domain can still be incorporated into functionalwhere the channel gate might reside.
The presence of solvent-exposed hydrophobic sur- channels (see Fayyazuddin et al., 2000).
The present demonstration that the LIVBP-like do-faces in globular proteins is usually indicative of inter-
domain interactions. In that respect, several exposed main of NR2A forms a modulatory Zn binding domain
combined with the observation that a similar domainhydrophobic residues that are found in the present
model of the NR2A LIVBP-like domain could constitute has been conserved in every eukaryotic iGluR subunit
characterized so far raises the question about the role ofputative interfaces of domain interaction. Thus, besides
interacting with the remainder of the protein through the this domain in these subunits. If all LIVBP-like domains
regulate channel activity, what is (are) their endogenousN-linker region, the LIVBP-like domain might also di-
rectly contact the LAOBP-like domain or the outer sur- ligand(s)? The fact that very few allosteric modulations
by extracellular substances have been identified forface of the membrane domain. In that respect, the obser-
vation that Zn (binding in the LIVBP-like domain) induces AMPA and kainate receptors (see Dingledine et al., 1999)
is clearly at odds with the idea that the LIVBP-like do-a change in the dissociation time constant of glutamate
(binding in the LAOBP-like domain) (see Paoletti et al., main is modulatory in all iGluR subunits. They may rather
fulfill different roles such as subunit oligomerization (see1997) might reflect direct interactions between the two
adjacent domains. In addition, given that iGluRs are above) or, in a more speculative view, receptor anchor-
ing through interaction with extracellular proteins. Theoligomers, exposed hydrophobic surfaces of the LIVBP-
like domain could also be involved in intersubunit con- situation may be different for the NMDA receptor sub-
types since numerous forms of allosteric modulationtacts. Of particular interest is the finding that LIVBP-like
domains of various receptors tend to dimerize and that of NMDA receptor by various substances have been
reported (see Dingledine et al., 1999). In particular, it isthis dimerization seems essential for the receptor’s
function (see, for instance, Romano et al. [1996] for interesting to note that the antagonism produced by
ifenprodil and its analogs on NMDA receptor displaysmGluR; Pace et al. [1999] for CaR). The hypothesis of
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purchased from Sigma. Zn was added as chloride salts (ZnCl2, ACSstriking similarities with Zn inhibition, implying a possi-
reagent quality) by dilution from 1 M stock solutions prepared inble common mechanism of action. In that respect, given
0.1 M HCl. Tricine was directly diluted to the final concentration (10that ifenprodil specifically acts on NR2B-containing re-
mM) and pH readjusted to 7.3. MTSET (methane-thio-sulfonate-
ceptors and, as suggested by Gallagher et al. (1996), ethyltrimethylammonium) was purchased from Toronto Research
may bind in the NR2B N-terminal region, it is tempting Chemicals. Ten millimolars stock solutions of MTSET were prepared
in bidistilled water and stored as 50 ml aliquots at 2208C. Immedi-to speculate that the NR2B LIVBP-like domain forms
ately before each application, a new aliquot was rapidly thawed andthe high-affinity ifenprodil binding site.
diluted to the final concentration. L-cysteine was directly diluted to
the final concentration (20 mM).Experimental Procedures
Sequence AlignmentsMolecular Biology
Psi-BLAST search was performed using the NR2A LIVBP-like do-The expression plasmids and the mutagenesis strategy have been
main as query (aa 32–380); BLAST 2.1.1, threshold value for inclusionpreviously described in Paoletti et al. (1997). The LIVBP-like domain
in subsequent iteration: 0.001; NCBI NR database (564 035 se-chimeras between NR2A and NR2B were made by introducing a
quences), until convergence (fifth iteration). The LIVBP sequenceSac2 silent site in both NR2A and NR2B and subsequent subcloning.
appeared significantly related to the NR2A one at the fourth iteration.In this chimera, aa M1-W390 of NR2A were swapped by aa M1-
Topohydrophobic residues of LIVBP are defined as hydrophobicW391 of NR2B. RNAs were transcribed from linearized cDNAs using
residues (A, F, I, L, M, V, W, Y) whose side chain is contacting (withinthe T7 RNA polymerase (Message Machine; Ambion).
5 A˚) at least three hydrophobic side chains from at least three other
secondary structure elements (see also Poupon and Mornon, 1998).Electrophysiology and Data Analysis
In Figure 2, we have highlighted the hydrophobic residues of theXenopus oocytes were prepared, injected, voltage clamped, and
NR2 subunits aligned with the topohydrophobic residues identifiedsuperfused as described in Paoletti et al. (1995, 1997) and Fayyazud-
in LIVBP. As T and S residues can frequently replace hydrophobicdin et al. (2000). The standard solution superfusing the oocytes
residues in secondary structure elements (b strands and a helices,contained (in mM): 100 NaCl, 5 HEPES, 0.3 BaCl2, and, in the majority
respectively) and P is frequently found at the border of such struc-of the experiments, 10 tricine. pH was adjusted to 7.3 with KOH.
tural elements (Callebaut et al., 1997), T, S, and P were also high-Tricine and ADA were used to buffer Zn as described in Fayyazuddin
lighted.et al. (2000). NMDA currents were induced by simultaneous applica-
The highlighted residues in the multiple alignment of Figure 3 aretion of saturating concentrations of glycine (100 mM) and L-gluta-
residues that are known or proposed to form the ligand bindingmate (100 mM).
pocket and/or contact the ligand in the different proteins containingNMDA currents were usually recorded and analyzed at 260 or
LIVBP-like domains. For vertebrate metabotropic receptors where230 mV. However, when Zn was used at high concentrations ($10
no structure is available yet, the following studies have used muta-mM), a voltage ramp protocol was required to separate Zn voltage-
genesis coupled to functional assays to identify the putative ligandindependent inhibition and Zn voltage-dependent pore block (see
binding residues: Bra¨uner-Osborne et al. (1999) for the rat CaR,Paoletti et al., 1997). In such conditions, 4 s 2100/150 mV ramps
O’Hara et al. (1993) and Hampson et al. (1999) for the rat mGluRs,were used (the capacitive and leakage currents were recorded be-
Galvez et al. (1999, 2000) for the rat GABA-BR1a. For 2LIV, 2LBP,fore agonist application and substracted from the glutamate/gly-
1PEA, 2DRI, 5ABP, and 1GCA, 3D structures have been obtained.cine-induced currents), and voltage-independent Zn inhibition was
However, only 1PEA, 5ABP, and 1GCA have been crystallized inquantified by measuring NMDA currents at 150 mV.
the ligand-bound “closed” confomation with the ligand contactingError bars represent SD.
residues from both domains. For these three proteins, we used
PDBsum to identify the ligand-contacting residues. LIVBP (E. coli)Chemical Modification by MTSET
has been crystallized both in a ligand-free and a L-leucine-boundWe initially tested the effect of MTSET on wt NR1/NR2A receptors
“open” conformation (Sack et al., 1989a). In this latter conformation,that contain 21 extracellular endogenous cysteines both on NR1
L-leucine contacts residues (highlighted in Figure 3) of the N-termi-and NR2A subunits. Treatment of wt NR1/NR2A receptors by MTSET
nal lobe only. LBP (E. coli) has been crystallized only in a ligand-concentrations as low as 10 mM for 1 min induced an increase in
free “open” conformation but determinants of L-leucine binding areZn sensivity. The mean ratios of the currents IZn/I0Zn for 5, 50, and
proposed to be similar as those identified in LIVBP (Sack et al.,500 nM Zn were, respectively: 0.73 6 0.06, 0.40 6 0.07, and 0.30 6
1989b).0.06 before MTSET treatment and 0.48 6 0.06, 0.29 6 0.05, and
0.24 6 0.04 after (n 5 13). This increased Zn sensitivity induced by
AcknowledgmentsMTSET appears to result from chemical modification of a single
residue, NR2A C399. Indeed, the NR2A C399A mutation, while leav-
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minimize the probability of MTSET to hit a Zn-free receptor. We
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partially reversed spontaneously on a time scale of several minutes
to few tens of minutes. Thus, to compare the effects on Zn sensitivity
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